| Literature DB >> 35355298 |
Miguel Ángel Fernández-Barroso1,2, Juan María García-Casco1,2, Yolanda Núñez2, Luisa Ramírez-Hidalgo3, Gema Matos3, María Muñoz2.
Abstract
Meat color is the first perceived sensory feature and one of the most important quality traits. Myoglobin is the main pigment in meat, giving meat its characteristic cherry-red color, highly appreciated by the consumers. In the current study, we used the RNA-seq technique to characterize the longissimus dorsi muscle transcriptome in two groups of Iberian pigs with divergent breeding values for myoglobin content. As a result, we identified 57 differentially expressed genes and transcripts (DEGs). Moreover, we have validated the RNA-seq expression of a set of genes by quantitative PCR (qPCR). Functional analyses revealed an enrichment of DEGs in biological processes related to oxidation (HBA1), lipid metabolism (ECH1, PLA2G10, PLD2), inflammation (CHST1, CD209, PLA2G10), and immune system (CD209, MX2, LGALS3, LGALS9). The upstream analysis showed a total of five transcriptional regulatory factors and eight master regulators that could moderate the expression of some DEGs, highlighting SPI1 and MAPK1, since they regulate the expression of DEGs involved in immune defense and inflammatory processes. Iberian pigs with high myoglobin content also showed higher expression of the HBA1 gene and both molecules, myoglobin and hemoglobin, have been described as having a protective effect against oxidative and inflammatory processes. Therefore, the HBA1 gene is a very promising candidate gene to harbor polymorphisms underlying myoglobin content, whereby further studies should be carried out for its potential use in an Iberian pig selection program.Entities:
Keywords: Iberian pig; RNA-seq; myoglobin content; transcriptome and functional analysis
Mesh:
Substances:
Year: 2022 PMID: 35355298 PMCID: PMC9314091 DOI: 10.1111/age.13195
Source DB: PubMed Journal: Anim Genet ISSN: 0268-9146 Impact factor: 2.884
FIGURE 1Volcano plot of differentially expressed genes (DEGs) and transcripts of High myoglobin group vs. Low myoglobin group. Red dots indicate DEGs with q‐value <0.10 and |Log2 fold change| > 0.58. Grey dots are non‐significant genes
Log2 fold change, basemean expression value in the High and Low myoglobin groups, p‐value, and q‐value, corresponding to the most relevant differentially expressed genes (DEGs)
| Gene | Log2 FC | High | Low |
|
|
|---|---|---|---|---|---|
|
| −1.23 | 27.56 | 65.85 | 1.33 × 10−04 | 0.093 |
|
| 0.68 | 247.10 | 154.71 | 9.13 × 10−06 | 0.007 |
|
| 0.73 | 286.49 | 172.22 | 8.69 × 10−05 | 0.055 |
|
| 0.82 | 185.83 | 104.97 | 6.74 × 10−04 | 0.089 |
|
| 0.85 | 14003.78 | 7759.99 | 1.00 × 10−05 | 0.025 |
|
| 0.93 | 570.37 | 299.29 | 4.36 × 10−05 | 0.029 |
|
| 0.97 | 91.26 | 46.57 | 3.15 × 10−04 | 0.069 |
|
| 0.98 | 175.16 | 88.68 | 3.82 × 10−05 | 0.027 |
|
| 1.03 | 371.36 | 181.74 | 3.22 × 10−05 | 0.025 |
|
| 1.29 | 181.23 | 73.37 | 4.97 × 10−07 | 0.002 |
|
| 1.37 | 327.64 | 126.65 | 3.47 × 10−04 | 0.085 |
|
| 1.86 | 342.77 | 94.59 | 3.44 × 10−06 | 0.006 |
|
| 5.42 | 7.74 | 0.181 | 2.16 × 10−05 | 0.068 |
High and Low: basemean expression value calculated from the coefficients (β 0 and β 1) estimated by the generalized linear model fit in DESeq2 (Love et al., 2014).
List of significantly overrepresented gene ontology (GO) terms related to myoglobin content on differentially expressed genes (DEGs) using FatiGO
| Term | Genes | Adjusted |
|---|---|---|
| GOBP | ||
| Prostaglandin secretion (GO:0032310) |
| 0.026 |
| Positive regulation of icosanoid secretion (GO:0032305) |
| 0.026 |
| Regulation of prostaglandin secretion (GO:0032306) |
| 0.026 |
| Positive regulation of prostaglandin secretion (GO:0032308) |
| 0.026 |
| Mitochondrial depolarization (GO:0051882) |
| 0.026 |
| Regulation of mitochondrial depolarization (GO:0051900) |
| 0.026 |
| Prostaglandin transport (GO:0015732) |
| 0.026 |
| Positive regulation of fatty acid transport (GO:2000193) |
| 0.028 |
| Regulation of icosanoid secretion (GO:0032303) |
| 0.034 |
| Monocarboxylic acid transport (GO:0015718) |
| 0.037 |
| Positive regulation of organic acid transport (GO:0032892) |
| 0.037 |
| Regulation of fatty acid transport (GO:2000191) |
| 0.040 |
| Reactive oxygen species metabolic process (GO:0072593) |
| 0.040 |
| T cell proliferation (GO:0042098) |
| 0.040 |
| Cartilage development (GO:0051216) |
| 0.040 |
| Cortical actin cytoskeleton organization (GO:0030866) |
| 0.040 |
| Positive regulation of ion transport (GO:0043270) |
| 0.040 |
| Positive regulation of cytoskeleton organization (GO:0051495) |
| 0.040 |
| Cortical cytoskeleton organization (GO:0030865) |
| 0.043 |
| Icosanoid secretion (GO:0032309) |
| 0.047 |
| Icosanoid transport (GO:0071715) |
| 0.047 |
| Fatty acid derivative transport (GO:1901571) |
| 0.047 |
| Connective tissue development (GO:0061448) |
| 0.047 |
| Phosphatidylglycerol metabolic process (GO:0046471) |
| 0.047 |
| GOslim | ||
| Proteinaceous extracellular matrix (GO:0005578) |
| 0.01 |
FIGURE 2Network of protein‐protein interactions predicted with string database. Same color nodes sharing multiple edges are grouped in the same cluster
Relevant enriched networks and functions related to myoglobin content identified in the set of differentially expressed genes between the High and Low groups identified by IPA software
| ID | Molecules in network | Score | Focus molecules | Functions |
|---|---|---|---|---|
| 1 |
| 54 | 21 | Dermatological diseases and conditions, immunological disease, organismal injury and abnormalities |
| 2 |
| 35 | 15 | Cell cycle, gene expression, lipid metabolism |
| 3 |
| 14 | 7 | Cell‐to‐cell signaling and interaction, hematological system development and function, immune cell trafficking |
| 4 | ANGPTL3, ANGPTL4, ANGPTL8, APOA5, | 2 | 1 | Cardiovascular disease, lipid metabolism, small molecule biochemistry |
FIGURE 3Gene network 1: dermatological diseases and conditions, immunological disease, organismal injury and abnormalities. Genes upregulated and downregulated in the High myoglobin group are represented in green and red colors respectively
FIGURE 4Gene network 2: cell cycle, gene expression, lipid metabolism. Genes upregulated and downregulated in the High myoglobin group are represented in green and red colors respectively
List of significant pathways (p‐value <0.05) identified in the set of differentially expressed genes according to the High and Low myoglobin groups identified by Ingenuity Pathway Analysis (IPA) software
| Canonical pathways |
| Ratio | Molecules |
|---|---|---|---|
| Phospholipases | 0.007 | 0.031 | PLA2G10, PLD2 |
| Antioxidant action of vitamin C | 0.019 | 0.018 | PLA2G10, PLD2 |
| Choline biosynthesis III | 0.028 | 0.067 | PLD2 |
| Inflammasome pathway | 0.038 | 0.050 | P2RX7 |
Ratio: number of differentially expressed genes in a pathway divided by the number of genes comprised in the same pathway.
List of significant upstream regulators identified in the set of differentially expressed genes according to the High and Low myoglobin (MB) groups (p‐value < 0.05 and z‐score >2 or <−2)
| Upstream regulator | Molecule type | PAS |
|
| Molecules in dataset |
|---|---|---|---|---|---|
| PRL | Cytokine | High MB | 2.22 | 2.35 × 10−04 | IFI44, IFI44L, IFI6, MGP, MX2 |
| IFNG | Cytokine | High MB | 2.04 | 7.49 × 10−03 | CD209, FBLN1, IFI44, IFI44L, IFI6, LGALS3, LGALS9, MX2 |
| IRF7 | Transcription regulator | High MB | 2.00 | 3.61 × 10−04 | IFI44, IFI44L, IFI6, MX2 |
| IL1RN | Cytokine | Low MB | −2.24 | 5.78 × 10−06 | IFI44, IFI44L, IFI6, LGALS9, MX2 |
| MAPK1 | Kinase | Low MB | −2.65 | 9.72 × 10−06 | FES, HBA1/HBA2, IFI44, IFI6, LGALS3, MX2, TRIM34 |
Abbreviation: PAS, predicted activation ratio.
Ingenuity Pathway Analysis (IPA)
| Master regulator | Molecule type | Participating regulators | PAS |
|
| Target molecules in dataset |
|---|---|---|---|---|---|---|
| MAPK1 | Kinase | MAPK1 | Low MB | −2.65 | 2.52 × 10−06 | FES, HBA1/HBA2, IFI44, IFI6, LGALS3, MX2, TRIM34 |
| IL1RN | Cytokine | IL1RN | Low MB | −2.24 | 5.16 × 10−06 | IFI44, IFI44L, IFI6, LGALS9, MX2 |
| PRL | Cytokine | PRL | High MB | 2.24 | 1.99 × 10−04 | IFI44, IFI44L, IFI6, MGP, MX2 |
| IRF7 | Transcription regulator | IRF7 | High MB | 2.00 | 3.15 × 10−04 | IFI44, IFI44L, IFI6, MX2 |
| MECP2 | Transcription regulator | MECP2, SPI1 | Low MB | −2.24 | 3.56 × 10−04 | CD209, HBA1/HBA2, IFI44, IFI44L, IFI6 |
| IFNA2 | Cytokine | IFNA2 | High MB | 2.00 | 5.91 × 10−04 | IFI44, IFI44L, IFI6, MX2 |
| SPI1 | Transcription regulator | SPI1 | High MB | 2.00 | 6.14 × 10−04 | CD209, IFI44, IFI44L, IFI6 |
| Hnf3 | Group | Estrogen receptor, FOXA1, FOXA2, FOXA3, Hnf3, IRF3, STAT5B | Low MB | −2.65 | 1.68 × 10−03 | COL12A1, FBLN1, IFI44, IFI44L, IFI6, MGP, RPRM |
List of significant master regulators (p < 0.05) with assigned z‐score identified in the set of differentially expressed genes according to High and Low myoglobin (MB) groups.
Abbreviation: PAS, predicted activation ratio.
FIGURE 5Master regulator effects network predicted in Iberian pigs fattened in an open‐air free‐range system. In the upper tier is SPI1 (predicted to be activated, blue color). In the middle, there are the genes whose expression changes in response to the activation of SPI1 (green upregulated for the High myoglobin group). Dashed lines between SPI1 and differentially expressed genes represent the interactions, predicted to be activated (blue lines) or predicted to be inhibited (orange lines). In the lower tier, the expected phenotypic activate function (adhesion of immune cells, blue color) is shown
Technical validation of RNA‐seq results by quantitative PCR (qPCR)
| Gene | qPCR | qPCR | Expression type | RNA‐seq | RNA‐seq |
|
| CCC |
|---|---|---|---|---|---|---|---|---|
| Log2 FC |
| Log2 FC |
| |||||
|
| 1.20 | 0.034 | H>L | 1.86 | 0.006 | 0.990 | 6.39 × 10−10 | 0.880 |
|
| 0.28 | 0.383 | NO DE | 0.54 | 0.460 | 0.969 | 2.25 × 10−7 | |
|
| 0.54 | 0.196 | NO DE | 0.85 | 0.145 | 0.902 | 5.91 × 10−5 | |
|
| 0.21 | 0.317 | NO DE | 0.65 | 0.473 | 0.861 | 3.24 × 10−4 | |
|
| 0.33 | 0.079 | H>L | 1.29 | 0.016 | 0.664 | 0.019 | |
|
| 0.01 | 0.282 | NO DE | 0.09 | 1 | 0.747 | 0.005 | |
|
| 0.96 | 0.119 | H>L | 0.97 | 0.069 | 0.623 | 0.041 | |
|
| −0.83 | 0.010 | L>H | −0.84 | 0.085 | 0.590 | 0.041 | |
|
| 0.47 | 0.027 | H>L | 0.93 | 4.36 × 10−5 | 0.727 | 0.007 | |
|
| 0.54 | 0.057 | H>L | 1.02 | 0.025 | 0.877 | 1.78 × 10−4 | |
|
| 0.42 | 0.036 | H>L | 0.83 | 0.089 | 0.810 | 0.001 | |
|
| 0.202 | 0.166 | – | – | – | – | – | – |
qPCR p‐value corresponds to the t’ student test analyzing the expression differences between the groups H and L; RNA‐seq q‐value corresponds to the RNA‐seq differential expression analyses and r 2 p‐value corresponds to the Pearson correlation analyses. Fold Change values (FC), Pearson correlations (r 2) and concordance correlation coefficient (CCC) between expression values obtained from both techniques.
Abbreviations: H>L, higher expression in High myoglobin (MB) group than in Low MB; L>H, higher expression in Low MB group than in High MB; NO DE, no differentially expressed in RNA‐seq experiment.